No Safety Surprises from Humira
Humira (adalimumab) is a medication used to treat a variety of diseases. As the medication is being prescribed to more and more patients, researchers wanted to see if there were any side effects they didn't know about before.
New Drug for Crohn's Patients
Maybe this is the end of long-term stomach aches and pains, at least for patients with Crohn's disease who don't respond to the common treatment.
New Psoriasis Hope
For those without psoriasis, the common autoimmune condition that generally manifests as raised red skin with silver-white patches of dead skin, the condition may appear to be just a minor cosmetic annoyance.
Psoriasis: Don't Hide From Help
As a child, Alisha B. had a few patches of what looked like a rash on her knees and elbows. She and her parents didn't think anything of it. Then things changed, and her skin has ever been the same since.
FDA Focus on TNF Blockers
A class of drugs is now under suspicion of causing cancer in children, adolescents and young adults under the age of 30. These are called Tumor Necrosis Factor (TNF) blockers, and the U.S. Food and Drug Administration (FDA) recently released an update regarding its ongoing safety review of these drugs.
Psoriasis Drugs Not Linked to Cardiovascular Problems
Early reports indicating drugs treating psoriasis were linked to major cardiovascular events seem to lack evidence.
Arthritis Drugs May Keep Diabetes at Bay
Even if a drug was meant to fight one disease, it often happens that the drug can protect patients against other health problems. This seems to be the case with some arthritis drugs.